Italy’s Recordati Starts $50 Million Greenfield Investment In Turkey
This article was originally published in PharmAsia News
Executive Summary
Italian pharmaceutical company Recordati invests $50 million in Turkey to establish a production facility in Tekirdag province to produce cardiovascular drugs.